Brody Olson1, Beth Gribble1, Jasmyni Dias1, Cassie Curryer1, Kha Vo2, Paul Kowal3, Julie Byles4. 1. Research Centre for Generational Health and Ageing, School of Medicine and Public Health, HMRI Building, University of Newcastle, Callaghan, NSW, Australia 2308. 2. The George Institute for Global Health, Sydney, Australia. 3. Research Centre for Generational Health and Ageing, School of Medicine and Public Health, HMRI Building, University of Newcastle, Callaghan, NSW, Australia 2308; WHO Study on global AGEing and adult health (SAGE), 20 Avenue Appia, CH -1211 Geneva, Switzerland. 4. Research Centre for Generational Health and Ageing, School of Medicine and Public Health, HMRI Building, University of Newcastle, Callaghan, NSW, Australia 2308. Electronic address: julie.byles@newcastle.edu.au.
Abstract
BACKGROUND: Screening reduces cervical cancer incidence and mortality. OBJECTIVE: To describe cervical cancer epidemiology and screening guidelines in six low- and middle-income countries (LMICs) participating in the Study on global AGEing and adult health (SAGE). SEARCH STRATEGY: Incidence, mortality, and screening-rate data were obtained for six LMICs and three higher-income comparator countries (Australia, USA, and UK). SCOPUS and PubMed were used to identify literature published after 2000 in English, using several screening-linked terms. SELECTION CRITERIA: Literature describing the use of cervical cancer screening guidelines in China, Ghana, India, Mexico, Russia, and South Africa were included. DATA COLLECTION AND ANALYSIS: Incidence, mortality trends, and screening rates were graphed and screening recommendations were summarized. MAIN RESULTS: Higher rates of cervical cancer incidence, mortality, and 5-year prevalence were found in LMICs compared with the comparator countries. LMICs with absent or newly implemented screening guidelines had the lowest rates of crude and effective cervical cancer screening, with high cancer incidence and mortality. Countries with established guidelines had higher screening rates and lower disease burden. Cost, inadequate knowledge, geographical location, and cultural views were common barriers to effective screening coverage. CONCLUSION: Work must continue to improve the implementation of affordable, relevant, and achievable methods to improve screening coverage in LMICs.
BACKGROUND: Screening reduces cervical cancer incidence and mortality. OBJECTIVE: To describe cervical cancer epidemiology and screening guidelines in six low- and middle-income countries (LMICs) participating in the Study on global AGEing and adult health (SAGE). SEARCH STRATEGY: Incidence, mortality, and screening-rate data were obtained for six LMICs and three higher-income comparator countries (Australia, USA, and UK). SCOPUS and PubMed were used to identify literature published after 2000 in English, using several screening-linked terms. SELECTION CRITERIA: Literature describing the use of cervical cancer screening guidelines in China, Ghana, India, Mexico, Russia, and South Africa were included. DATA COLLECTION AND ANALYSIS: Incidence, mortality trends, and screening rates were graphed and screening recommendations were summarized. MAIN RESULTS: Higher rates of cervical cancer incidence, mortality, and 5-year prevalence were found in LMICs compared with the comparator countries. LMICs with absent or newly implemented screening guidelines had the lowest rates of crude and effective cervical cancer screening, with high cancer incidence and mortality. Countries with established guidelines had higher screening rates and lower disease burden. Cost, inadequate knowledge, geographical location, and cultural views were common barriers to effective screening coverage. CONCLUSION: Work must continue to improve the implementation of affordable, relevant, and achievable methods to improve screening coverage in LMICs.
Authors: Sanghyuk S Shin; Catherine L Carpenter; Maria L Ekstrand; Qiao Wang; Surbhi Grover; Nicola M Zetola; Kartik Yadav; Sanjeev Sinha; Adeline M Nyamathi Journal: Int J STD AIDS Date: 2019-02-27 Impact factor: 1.359
Authors: Margot Kunckler; Fanny Schumacher; Bruno Kenfack; Rosa Catarino; Manuela Viviano; Eveline Tincho; Pierre-Marie Tebeu; Liliane Temogne; Pierre Vassilakos; Patrick Petignat Journal: Cancer Med Date: 2017-06-04 Impact factor: 4.452
Authors: Zacharie Ndizeye; Davy Vanden Broeck; Heleen Vermandere; John Paul Bogers; Jean-Pierre Van Geertruyden Journal: Global Health Date: 2018-01-16 Impact factor: 4.185